Tandem Diabetes Care, Inc.

Public Equity (NASDAQ)Medical DevicesDiabetesPublic Company

📍 San Diego, CA, USA• Founded 2006

StreetZero Signal 53

Be the first to signal interest

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. develops and manufactures insulin delivery and diabetes management systems. Its main products include the t:slim X2 insulin pump integrated with Control-IQ automated insulin delivery technology. The company is publicly traded on NASDAQ under ticker TNDM and focuses on improving outcomes for people with diabetes through connected devices and software.

LATEST FUNDINGRule 144

$32K

Announced 2026-10-27

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for Tandem Diabetes Care, Inc..

Create free account Sign in

Free plan includes 3 full deal profiles every month.

EMPLOYEES—

FOUNDED2006

HQSan Diego, CA, USA

Industry

Public Equity (NASDAQ)

Investors

Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.

Key highlights

Completed $32,130 Rule 144 transaction
Publicly traded on NASDAQ under TNDM
Headquartered in San Diego, CA
Focuses on automated insulin delivery systems

Ask StreetZero about Tandem Diabetes Care, Inc.

Put our AI to work on this deal.

What is Tandem Diabetes Care, Inc.'s value proposition?Who are Tandem Diabetes Care, Inc.'s competitors?Why does this raise matter?Summarize Tandem Diabetes Care, Inc. for an investor.

Similar companies

Other Public Equity (NASDAQ) deals, ranked by Signal.

Paylocity Holding Corporation

$66.0M

BENTLEY SYSTEMS INC

$67.5M

Crowdstrike Holdings, Inc.

$141.0M

Palo Alto Networks Inc

$201.4M

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.